U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07202039) titled 'Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine' on Sept. 23.
Brief Summary: This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine
Study Start Date: Jan. 05, 2026
Study Type: INTERVENTIONAL
Condition:
Tobacco-flavored EC
Sweet-Cooling EC
Sweet Non-cooling EC
Intervention:
BEHAVIORAL: Brief individual counseling sessions
Five brief, individual counseling sessions will provide education, behavioral support, and motiv...